Gylden Pharma Ltd
Gylden Pharma Ltd
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of PepGNP-ChikV in Healthy Volunteers | Alphavirus infectious disease, Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, infectious disease, vector-borne disease, viral infectious disease | Not yet recruiting | Early phase 1 | 2026-04-29 | NCT07394426 | |
| Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19) | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Not yet recruiting | Phase 1 / Phase 2 | 2025-02-24 | NCT05633446 |